The effect of cladribine on some parameters of blood and cerebrospinal fluid in patients with relapsing-remitting multiple sclerosis (RR-MS)

Ann Univ Mariae Curie Sklodowska Med. 2000:55:221-5.

Authors

Z Stelmasiak¹, H Bartosik-Psujek, E Belniak-Legieć, K Mitosek-Szewczyk

Affiliation

¹ Katedra i Klinika Neurologii Akademii Medycznej w Lublinie.

PMID: 11482077

No abstract available

Publication types

Clinical Trial

MeSH terms

Adult
Cerebrospinal Fluid Proteins / analysis*
Cladribine / pharmacology*
Female
Granulocytes / drug effects
Humans
Injections, Subcutaneous
Kidney Function Tests
Leukocyte Count
Liver Function Tests
Lymphocyte Count
Male
Multiple Sclerosis, Relapsing-Remitting / blood*
Multiple Sclerosis, Relapsing-Remitting / cerebrospinal fluid
Multiple Sclerosis, Relapsing-Remitting / drug therapy*
Multiple Sclerosis, Relapsing-Remitting / physiopathology

Substances

Cerebrospinal Fluid Proteins
Cladribine